141 related articles for article (PubMed ID: 18996005)
1. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
Kleibl Z; Havranek O; Hlavata I; Novotny J; Sevcik J; Pohlreich P; Soucek P
Eur J Cancer; 2009 Mar; 45(4):618-24. PubMed ID: 18996005
[TBL] [Abstract][Full Text] [Related]
2. CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.
Mohelnikova-Duchonova B; Havranek O; Hlavata I; Foretova L; Kleibl Z; Pohlreich P; Soucek P
Cancer Epidemiol; 2010 Oct; 34(5):656-8. PubMed ID: 20643596
[TBL] [Abstract][Full Text] [Related]
3. CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Bayram S; Topaktaş M; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2012 Oct; 36(5):453-7. PubMed ID: 22521562
[TBL] [Abstract][Full Text] [Related]
4. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J
Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448
[TBL] [Abstract][Full Text] [Related]
5. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
van Puijenbroek M; van Asperen CJ; van Mil A; Devilee P; van Wezel T; Morreau H
J Pathol; 2005 Jun; 206(2):198-204. PubMed ID: 15818573
[TBL] [Abstract][Full Text] [Related]
6. CHEK2 I157T associates with familial and sporadic colorectal cancer.
Kilpivaara O; Alhopuro P; Vahteristo P; Aaltonen LA; Nevanlinna H
J Med Genet; 2006 Jul; 43(7):e34. PubMed ID: 16816021
[TBL] [Abstract][Full Text] [Related]
7. CHEK2 I157T and colorectal cancer in Bulgaria.
Konstantinova D; Kadiyska T; Sokolova V; Kaneva R; Mirchev M; Savov A; Aleksandrova A; Nedin D; Kostadinov E; Damyanov D; Kremensky I; Mitev V
J BUON; 2010; 15(2):314-7. PubMed ID: 20658728
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and the CHEK2 1100delC mutation.
de Jong MM; Nolte IM; Te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Niessen RC; Berends MJ; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
Genes Chromosomes Cancer; 2005 Aug; 43(4):377-82. PubMed ID: 15852425
[TBL] [Abstract][Full Text] [Related]
9. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of breast cancer associated with CHEK2*1100delC.
Weischer M; Bojesen SE; Tybjaerg-Hansen A; Axelsson CK; Nordestgaard BG
J Clin Oncol; 2007 Jan; 25(1):57-63. PubMed ID: 16880452
[TBL] [Abstract][Full Text] [Related]
11. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; van de Wetering T; Narod SA; Lubiński J
Breast Cancer Res Treat; 2007 Mar; 102(1):119-22. PubMed ID: 16897426
[TBL] [Abstract][Full Text] [Related]
12. CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
Wasielewski M; Vasen H; Wijnen J; Hooning M; Dooijes D; Tops C; Klijn JG; Meijers-Heijboer H; Schutte M
Clin Cancer Res; 2008 Aug; 14(15):4989-94. PubMed ID: 18676774
[TBL] [Abstract][Full Text] [Related]
13. CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden.
Wagenius M; Borg A; Johansson L; Giwercman A; Bratt O
Scand J Urol Nephrol; 2006; 40(1):23-5. PubMed ID: 16452051
[TBL] [Abstract][Full Text] [Related]
14. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations.
Kleibl Z; Havranek O; Novotny J; Kleiblova P; Soucek P; Pohlreich P
Breast Cancer Res Treat; 2008 Nov; 112(1):159-64. PubMed ID: 18058223
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
[TBL] [Abstract][Full Text] [Related]
17. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
Cybulski C; Masojc B; Oszutowska D; Jaworowska E; Grodzki T; Waloszczyk P; Serwatowski P; Pankowski J; Huzarski T; Byrski T; Górski B; Jakubowska A; Debniak T; Wokolorczyk D; Gronwald J; Tarnowska C; Serrano-Fernández P; Lubinski J; Narod SA
Carcinogenesis; 2008 Apr; 29(4):762-5. PubMed ID: 18281249
[TBL] [Abstract][Full Text] [Related]
18. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190
[TBL] [Abstract][Full Text] [Related]
19. The CHEK2 1100delC variant in Swedish colorectal cancer.
Djureinovic T; Lindblom A; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Eiberg H; Bisgaard ML
Anticancer Res; 2006; 26(6C):4885-8. PubMed ID: 17214356
[TBL] [Abstract][Full Text] [Related]
20. The CHEK2 gene and inherited breast cancer susceptibility.
Nevanlinna H; Bartek J
Oncogene; 2006 Sep; 25(43):5912-9. PubMed ID: 16998506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
